Author:
Takura Tomoyuki,Tachibana Kouichi,Isshiki Takaaki,Sumitsuji Satoru,Kuroda Tadashi,Mizote Isamu,Ide Seiko,Nanto Shinsuke
Funder
Japanese Society for Medical Economics of Coronary Vascular Disease (JEC)
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference30 articles.
1. Kuukasjärvi P, Räsänen P, Malmivaara A, Aronen P, Sintonen H. Economic evaluation of drug-eluting stents: a systematic literature review and model-based cost-utility analysis. Int J Technol Assess Health Care. 2007;23(4):473–9.
2. Fearon WF, Shilane D, Pijls NH, Boothroyd DB, Tonino PA, Barbato E, Jüni P, De Bruyne B. Hlatky MA; fractional flow reserve versus angiography for multivessel evaluation 2 (FAME 2) investigators. cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. Circulation. 2013;128(12):1335–40.
3. Guidelines manual-appraising orphan drugs, NICE, http://www.nice.org.uk , 2006.
4. Anderson JL, Heidenreich PA, Barnett PG, Creager MA, Fonarow GC, Gibbons RJ, Halperin JL, Hlatky MA, Jacobs AK, Mark DB, Masoudi FA, Peterson ED, Shaw LJ. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2304–22.
5. Takura T, Sawa Y, Kyo S. Medical and economic values and issues in organ transplantation. JPN J Transplant. 2009;44:225–8.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献